Business
VVT Med Closes $1,065,664 First Tranche of Private Placement of Units
VVT Med Closes $1,065,664 First Tranche of Private Placement of Units Canada NewsWire ...
About this update from Vvt Med Inc.
[{"type":"text","content":"\n\n\nVVT Med Closes $1,065,664 First Tranche of Private Placement of Units\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nCanada NewsWire\n\n\nVANCOUVER, BC, April 22, 2026 /CNW/ - VVT Med Inc. (TSXV: VVTM) (the \"Company\" or \"VVT\"), a leader in minimally invasive, non-thermal and non-tumescent solutions for venous disease, is pleased to announce that, on April 21, 2026,  the Company completed the first tranche of its previously announced non-brokered private placement offering for up to gross proceeds of $3,000,000, issuing 4,262,654 units (each, a \"Unit\") at a price of $0.25 per Unit for gross proceeds of $1,065,663.50 (the \"Offering\").\nEach Unit consists of one common share of the Company (each, a \"Common Share\") and one-half of one common share purchase warrant (each whole warrant, a \"Warrant\"). Each whole Warrant is exercisable into one Common Share at an exercise price of $0.375 per Warrant Share for a period of 24 months from the date of issuance.The net proceeds from the Offering will be used to support expanded U.S. and global commercialization efforts, product manufacturing to accommodate anticipated demand, working capital and general corporate purposes. The securities issued pursuant to the Offering will be subject to a four-month hold period from the date of issuance in accordance with applicable securities laws and the policies of the TSX Venture Exchange. The Company anticipates closing a second tranche of the Offering in due course.In connection with the Offering, the Company paid certain eligible finders a cash fee of up to 8% of the gross proceeds raised in respect of the Offering from subscribers introduced by such finders to the Company, for a total of $27,800. In addition, the Company issued to eligible finders such number of finder warrants (each, a \"Finder Warrant\") equal to 8% of the number of Units sold under the Offering to subscribers introduced by such finders to the Company, for a total of 111,200 Finder Warrants. Each Finder Warrant will entitle the holder to acquire one Common Share at an exercise price of $0.375 per sh...